121 filings
Page 6 of 7
8-K
4r6cauekj fd
5 Aug 15
Fate Therapeutics Reports Second Quarter 2015 Financial Results
12:00am
8-K
oy0jdbkl
21 May 15
Fate Therapeutics Announces Proposed Public Offering of Common Stock
12:00am
8-K
bflu4vbo3atgi4g
15 May 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
oi74zut9wbj1n
7 May 15
Fate Therapeutics Reports First Quarter 2015 Financial Results
12:00am
8-K
8r45wtpfy
6 May 15
Other Events
12:00am
8-K
8rxj20gqef29evscfa0s
6 May 15
Entry into a Material Definitive Agreement
12:00am
8-K
cpi48v9cv4dtgb 3egsj
12 Mar 15
Fate Therapeutics Reports Year-End 2014 Financial Results
12:00am
8-K
5kknp9u6iqr4
30 Jan 15
Departure of Directors or Certain Officers
12:00am
8-K
ourr8gs1v6x7o
7 Jan 15
Departure of Directors or Certain Officers
12:00am
8-K
awvxpaw2imzowc4ixag
30 Dec 14
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
ailetlk
18 Dec 14
Fate Therapeutics Announces Interim Data From Ongoing Phase 2 PUMA Study of PROHEMA in Adults with Hematologic Malignancies
12:00am
8-K
5q26q6svaa
17 Nov 14
Results of Operations and Financial Condition
12:00am
8-K
5k6184b4d9nx57 pftb
12 Nov 14
Fate Therapeutics Reports Third Quarter 2014 Financial Results
12:00am
8-K
gxmlmuwu
12 Aug 14
Fate Therapeutics Reports Second Quarter 2014 Financial Results
12:00am
8-K
b2mosa7
5 Aug 14
Entry into a Material Definitive Agreement
12:00am
8-K
nei4bvc99y7pxr0xmvig
11 Jun 14
Departure of Directors or Certain Officers
12:00am
8-K
q5rselg4a5mif9 uzp6r
13 May 14
Fate Therapeutics Reports First Quarter 2014 Financial Results
12:00am
8-K
8l34ihh8h0xffysc
17 Mar 14
Fate Therapeutics Appoints Dr. Robert S. Epstein to its Board of Directors
12:00am
8-K
cljfglxpo
17 Mar 14
Fate Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results
12:00am
8-K
sybacikt8wmsebru
10 Jan 14
Departure of Directors or Certain Officers
12:00am